![](/img/cover-not-exists.png)
In vivo pharmacological characterization of the structurally novel, potent, selective mGlu2/3 receptor agonist LY404039 in animal models of psychiatric disorders
Linda M. Rorick-Kehn, Bryan G. Johnson, Karen M. Knitowski, Craig R. Salhoff, Jeffrey M. Witkin, Kenneth W. Perry, Kelly I. Griffey, Joseph P. Tizzano, James A. Monn, David L. McKinzie, Darryle D. SchVolume:
193
Language:
english
Pages:
16
DOI:
10.1007/s00213-007-0758-3
Date:
July, 2007
File:
PDF, 731 KB
english, 2007